Willamette Valley Cancer Institute and Research Center

Statistics

Publications

572

Citations

15.1K

Authors

Location

Eugene, United States

Also known as WVCI

Willamette Valley Cancer Institute and Research Center is a healthcare institution in Eugene, United States known for medicine, oncology, and immunotherapy.

Homepage ROR

Top concepts

MedicineOncologyImmunotherapyPharmacologyCancer PharmacologyCancer ImmunotherapyHematologic Malignancy TherapyPharmacotherapyChemotherapyChronic Lymphocytic Leukemia Therapy

Publications

572

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Richard R. Furman, Steven Coutré et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

Medicine, Hematology, Oncology +12

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial

Jeff P. Sharman, Miklós Egyed, Wojciech Jurczak et al. · The Lancet · 2020 · 612 citations · Full text

Medicine, Hematology, Pharmacology +10

Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial

Susan O’Brien, Richard R. Furman, Steven Coutré et al. · The Lancet Oncology · 2013 · 465 citations

Medicine, Immunology, Oncology +10

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)

Kathleen N. Moore, Michael A. Bookman, Jalid Sehouli et al. · Journal of Clinical Oncology · 2021 · 406 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study

Éric Pujade-Lauraine, Keiichi Fujiwara, Jonathan A. Ledermann et al. · The Lancet Oncology · 2021 · 405 citations · Full text

Medicine, Gynecology, Oncology +13

1–5 of 572

Authors

JP
Jeff P. Sharman
Willamette Valley Cancer Institute and Research Center, United States
449 publications · 16.2K citations
48
h-index
KS
Kathryn S. Kolibaba
Willamette Valley Cancer Institute and Research Center, United States
114 publications · 5.3K citations
27
h-index
CA
Charles Anderson
Willamette Valley Cancer Institute and Research Center, United States
114 publications · 2.9K citations
21
h-index
CL
Calvin Lee
Willamette Valley Cancer Institute and Research Center, United States
92 publications · 1.3K citations
18
h-index
CA
Christopher A. Yasenchak
Willamette Valley Cancer Institute and Research Center, United States
95 publications · 1K citations
16
h-index

1–5 of 17